港股詳情

本页面由TTMF Limited提供服务

旺山旺水-B待上市

33.370

0.000

成交量：- -

成交額：- -

市值：55.93億

市盈率：- -

高：33.370

開：33.370

低：33.370

收：33.370

52周最高：33.370

52周最低：33.370

股本：1.68億

香港流通股本：6,667.71萬

量比：- -

換手率：- -

股息：- -

股息率：- -

淨資產收益率：-132.51%

總資產收益率：-18.15%

市淨率：34.34

市盈率(LYR):- -

市銷率: 433.87

1

开始申购

10/28

2

申购截止

11/03 09:30

3

公布中签

11/04

4

暗盘

11/05 16:15 - 18:30

5

挂牌上市

11/06

總覽公司新聞公告

智通港股投資日誌|10月29日

新股招股｜旺山旺水-B今起招股，一手入場費6868.57港元

老虎资讯综合

旺山旺水-B(02630)擬全球發售1759.78萬股H股預計11月6日上市

新股解讀|旺山旺水：從盈利642萬到虧損2.18億九大管線背後的現金流懸崖與百億市場豪賭

智通财经网

新股消息 | 旺山旺水通過港交所聆訊已搭建起多元化的九個創新資產管線

旺山旺水通過港交所聆訊，已搭建起多元化的九個創新資產管線

新股前瞻丨旺山旺水兩度衝港股背後：新冠紅利消散，25人銷售團隊需撐起42億估值？

新股消息 | 旺山旺水二次遞表港交所，營業收入驟降且持續虧損

新股消息 | 旺山旺水港股IPO招股書失效

旺山旺水港股IPO及境內未上市股份「全流通」獲中國證監會備案

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02630/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02630","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02630\",,,,,undefined,":{"symbol":"02630","market":"HK","secType":"STK","nameCN":"旺山旺水-B","latestPrice":33.37,"timestamp":1762243200000,"preClose":33.37,"halted":9,"volume":0,"delay":0,"floatShares":66677100,"shares":167597800,"eps":0,"marketStatus":"待上市","change":0,"latestTime":"11-04 16:00:00","open":33.37,"high":33.37,"low":33.37,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1762392600000},"marketStatusCode":8,"adr":0,"listingDate":1762358400000,"exchange":"SEHK","adjPreClose":33.37,"openAndCloseTimeList":[[1762219800000,1762228800000],[1762232400000,1762243200000]],"volumeRatio":0,"ipoDetail":{"name":"旺山旺水－Ｂ","exchange":"SEHK","listingDate":"2025-11-06","sharesOutstanding":167597800,"sharesFloat":167597800,"offerAmount":17597800,"priceRange":"32.0-34.0","market":"HK","openProspectusDate":"2025-10-28","openProspectusUrl":"https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1028/2025102800018_c.pdf","purchaseBeginDate":"2025-10-28","purchaseEndDate":"2025-11-01","winningDate":"2025-11-05","currency":"HKD","minPurchaseQuantity":200,"peRate":-24.8,"use":"1、38.0%（或约198.0百万港元）将用于我们核心产品的研发；\n2、27.0%（或约140.7百万港元）将用于我们其他候选产品的研发；\n3、10.0%（或约52.1百万港元）将用于建设我们的青岛工厂；\n4、15.0%（或约78.2百万港元）将用于强化我们的销售及营销能力；\n5、10.0%（或约52.1百万港元），将用于营运资金及其他一般公司用途。","industryId":"204005","industryName":"医疗保健","business":"公司成立于2013年，是一家综合一体化生物医药公司，致力于发现、开发和商业化创新小分子药物。","subscribed":0,"marketCap":5593000000,"minimumCapital":6868.57,"overAllotment":true,"lotSize":200,"issueOpenRate":0.1,"subscribeGear":"200,400,600,800,1000,1200,1400,1600,1800,2000,3000,4000,5000,6000,7000,8000,9000,10000,15000,20000,25000,30000,35000,40000,45000,50000,60000,70000,80000,90000,100000,120000,140000,160000,180000,200000,250000,300000,350000,400000,450000,500000,600000,700000,800000,879800"},"greyMarketDetail":{"greyDate":"2025-11-05","greyDateTimestamp":1762272000000,"greyOpeningTime":1762330500000,"greyClosingTime":1762338600000,"showGreyQuote":false,"openProspectusDate":"2025-10-28","listingDate":"2025-11-06"},"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02630\",,,,,undefined,":{"symbol":"02630","floatShares":66677100,"roa":"-18.15%","roe":"-132.51%","lyrEps":0,"shares":167597800,"dividePrice":0,"high":33.37,"amplitude":0,"preClose":33.37,"low":33.37,"week52Low":33.37,"pbRate":"34.34","psRate":"433.87","week52High":33.37,"institutionHeld":0,"latestPrice":33.37,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":33.37},"@#url:\"https://hktrade.skytigris.com/ipos/general/02630\",,undefined,":{"id":9000,"type":"COMMON","ipoName":"02630-IPO","symbol":"02630","companyName":"蘇州旺山旺水","market":"HK","currency":"HKD","status":"CLOSED","underwriter":"中国国际金融香港证券有限公司","lotSize":200,"minQty":200,"expectedOfferingSize":17597800,"openingDate":1761615000000,"closingDate":1762133400000,"commonClosingDate":1762133400000,"allotmentDate":1762185600000,"listDate":1762358400000,"marginable":true,"latestPrice":34,"minPrice":32,"maxPrice":34,"allocationPrice":33.37,"prospectusUrl":"https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1028/2025102800018_c.pdf","allowedQuantities":[200,400,600,800,1000,1200,1400,1600,1800,2000,3000,4000,5000,6000,7000,8000,9000,10000,15000,20000,25000,30000,35000,40000,45000,50000,60000,70000,80000,90000,100000,120000,140000,160000,180000,200000,250000,300000,350000,400000,450000,500000,600000,700000,800000,879800],"recommend":false,"isHint":false,"interestStartDate":1762099200000,"interestEndDate":1762099200000,"delayAllocate":false,"isSupportGreyMarket":true,"greyMarketTradeDate":1762330500000,"transactionRate":0.010085,"gstFeeRate":0,"rank":100,"subscribed":false,"signed":false,"financingInfos":[],"financingNotifyEnabled":false,"financingNotifySubscribed":false,"subscriptionMethods":[],"latestClosingDate":1762287333795,"subscribedFinanceRatio":4674.68,"subscribedRatio":0,"forecastRatio":5609.62,"raiseMoney":59830000.00000001,"totalMargin":279701380000,"quoteInfoUpdatedAt":1762287014140,"prospectusUpdatedAt":1762136592000,"forecastMarketValue":5530727400,"minForecastMarketValue":5363129600,"maxForecastMarketValue":5698325200,"sharesOutstanding":167597800,"business":"公司成立於2013年，是一家綜合一體化生物醫藥公司，致力於發現、開發和商業化創新小分子藥物。","greyOpeningTime":1762330500000,"greyClosingTime":1762338600000,"tradable":false},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02630\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2579996149","title":"智通港股投資日誌|10月29日","url":"https://stock-news.laohu8.com/highlight/detail?id=2579996149","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579996149?lang=zh_tw&edition=fundamental","pubTime":"2025-10-29 00:00","pubTimestamp":1761667202,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，2025年10月29日，港股上市公司投资日志如下：    类别 公司  新股活动旺山旺水-B(招股中)均胜电子(招股中)小马智行-W(招股中)文远知行-W(招股中)赛力斯(招股中) 业绩公布日江苏宁沪高速公路安德利果汁天齐锂业广和通山东黄金东江环保中金公司百威亚太龙源电力中国石油化工股份 股东大会召开日天岳先进龙源电力远大住工","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1361734.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1129","SG9999000459.SGD","09927","LU0543330483.HKD","BK1169","LU0762540952.USD","00699","SG9999014674.SGD","BK1104","LU0320764755.SGD","LU0672654166.SGD","LU0197773160.USD","LU0630378692.HKD","BK4124","LU0762542818.HKD","02631","BK1180","BK4609","LU0762541174.USD","02630","01876","00800","LU0128522157.USD","09696","BK1531","LU0630378429.USD","LU0831093199.SGD","BK1258","BK1578","LU0029875118.USD","SG9999001903.USD","LU0197773673.USD","BK1604","BK1510","BK1229","BK1589"],"gpt_icon":0},{"id":"1134884079","title":"新股招股｜旺山旺水-B今起招股，一手入場費6868.57港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1134884079","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134884079?lang=zh_tw&edition=fundamental","pubTime":"2025-10-28 07:30","pubTimestamp":1761607847,"startTime":"0","endTime":"0","summary":"10月28日，旺山旺水-B(02630)于10月28日-11月3日招股，拟全球发售1759.78万股H股，其中香港公开发售占10%，国际发售占90%(可予重新分配)，另有15%超额配股权。每股发售价32-34港元，H股将以每手200股H股为买卖单位，预计H股将于11月6日在联交所开始买卖。申购阶梯：每手200股，入场费6868.57港元。乙组门槛为16万股，申购所需资金约549.49万港元。","market":"hk","thumbnail":"https://static.tigerbbs.com/03b737852f586e2640047e4e68a010a4","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/03b737852f586e2640047e4e68a010a4"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"新股招股｜旺山旺水-B今起招股，一手入场费6868.57港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02630"],"gpt_icon":0},{"id":"2578672526","title":"旺山旺水-B(02630)擬全球發售1759.78萬股H股 預計11月6日上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2578672526","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578672526?lang=zh_tw&edition=fundamental","pubTime":"2025-10-28 06:29","pubTimestamp":1761604145,"startTime":"0","endTime":"0","summary":"智通财经APP讯，旺山旺水-B 于2025年10月28日-2025年11月3日招股，拟全球发售1759.78万股H股，其中香港公开发售占10%，国际发售占90%，另有15%超额配股权。每股发售价32-34港元，H股将以每手200股H股为买卖单位，预计H股将于2025年11月6日(星期四)上午九时正在联交所开始买卖。该公司已获取并开发了两款核心产品LV232及TPN171。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1360975.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","02630","LU0170899867.USD","BK4208","LU2346227817.USD","BK4588"],"gpt_icon":0},{"id":"2578508496","title":"新股解讀|旺山旺水：從盈利642萬到虧損2.18億 九大管線背後的現金流懸崖與百億市場豪賭","url":"https://stock-news.laohu8.com/highlight/detail?id=2578508496","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578508496?lang=zh_tw&edition=fundamental","pubTime":"2025-10-25 21:24","pubTimestamp":1761398676,"startTime":"0","endTime":"0","summary":"旺山旺水的财务状况呈现出明显的波动性。收入大幅下滑的同时，旺山旺水的研发投入却始终保持在高位。招股书显示，旺山旺水已搭建九个创新资产管线，其中两项处于商业化阶段，四项处于临床阶段，三项处于临床前阶段。深入分析旺山旺水的现金流量表，最引人关注的是其经营活动现金流量的剧烈波动。旺山旺水的现金流状况并非个例。旺山旺水核心产品TPN171作为新一代PDE5抑制剂，向百亿规模的勃起功能障碍治疗市场发起冲击。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1359893.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"新股解读|旺山旺水：从盈利642万到亏损2.18亿 九大管线背后的现金流悬崖与百亿市场豪赌","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02630"],"gpt_icon":0},{"id":"2576859888","title":"新股消息 | 旺山旺水通過港交所聆訊 已搭建起多元化的九個創新資產管線","url":"https://stock-news.laohu8.com/highlight/detail?id=2576859888","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576859888?lang=zh_tw&edition=fundamental","pubTime":"2025-10-20 19:36","pubTimestamp":1760960188,"startTime":"0","endTime":"0","summary":"","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02630"],"gpt_icon":0},{"id":"2576859886","title":"旺山旺水通過港交所聆訊，已搭建起多元化的九個創新資產管線","url":"https://stock-news.laohu8.com/highlight/detail?id=2576859886","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576859886?lang=zh_tw&edition=fundamental","pubTime":"2025-10-20 19:36","pubTimestamp":1760960188,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，据港交所10月20日披露，苏州旺山旺水生物医药股份有限公司通过港交所主板上市聆讯，中信证券为其独家保荐人。截至最后实际可行日期，旺山旺水已搭建多元化的九个创新资产管线，其中两项处于商业化阶段，四项处于临床阶段，三项处于临床前阶段。旺山旺水已获取并开发了两款核心产品LV232及TPN171。旺山旺水的内部销售及营销团队主要负责在中国及乌兹别克斯坦通过各种营销活动推广公司的产品并通过不同渠道进行销售。","market":"hk","thumbnail":"https://static.tigerbbs.com/6b69e234a63c2c0a69ccede7b0faaa18","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6b69e234a63c2c0a69ccede7b0faaa18"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1357223.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02630"],"gpt_icon":0},{"id":"2557037681","title":"新股前瞻丨旺山旺水兩度衝港股背後：新冠紅利消散，25人銷售團隊需撐起42億估值？","url":"https://stock-news.laohu8.com/highlight/detail?id=2557037681","media":"智通财经","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557037681?lang=zh_tw&edition=fundamental","pubTime":"2025-08-06 19:04","pubTimestamp":1754478259,"startTime":"0","endTime":"0","summary":"据招股书显示，旺山旺水收入主要来源于授权VV116、提供CRO服务以及药品销售。不同物种的动物研究证实，利巴韦林具有显著的致畸或胚胎致死毒性。2025年4月在中国启动LV232用于治疗抑郁症的II期临床试验，并预计将于2026年下半年完成试验。截至最后实际可行日期，24款创新小分子抗抑郁药已在中国获批上市。","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1326458.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02630","07226","YANG","HSTECH","BK4614"],"gpt_icon":1},{"id":"2555833434","title":"新股消息 | 旺山旺水二次遞表港交所，營業收入驟降且持續虧損","url":"https://stock-news.laohu8.com/highlight/detail?id=2555833434","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555833434?lang=zh_tw&edition=fundamental","pubTime":"2025-08-01 11:32","pubTimestamp":1754019137,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，据港交所7月31日披露，苏州旺山旺水生物医药股份有限公司递表港交所主板，中信证券为其独家保荐人。VV116、 LV232及TPN171分别专门靶向抗病毒药物市场、神经精神药物市场和生殖健康药物市场，并已准备好满足重大的临床需求。财务方面，于2023年度、2024年度、2025年截至4月30日止四个月，旺山旺水实现收入分别约为2亿元、1183.2万元、1295.8万元人民币；同期，年内/期内利润分别约为642.7万元、-2.18亿元、-1.12亿元人民币。","market":"sh","thumbnail":"https://static.tigerbbs.com/22fb0a544aa253b668379d9f58bbe5a9","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/22fb0a544aa253b668379d9f58bbe5a9"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1324432.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02630"],"gpt_icon":0},{"id":"2554469617","title":"新股消息 | 旺山旺水港股IPO招股書失效","url":"https://stock-news.laohu8.com/highlight/detail?id=2554469617","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554469617?lang=zh_tw&edition=fundamental","pubTime":"2025-07-28 07:03","pubTimestamp":1753657422,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，苏州旺山旺水生物医药股份有限公司于2025年1月27日所递交的港股招股书满6个月，于2025年7月27日失效，递表时中信证券为独家保荐人。招股书显示，旺山旺水是一家综合一体化生物医药公司，致力于发现、开发和商业化创新小分子药物。TPN171是一款潜在同类最佳、高效及高选择性的磷酸二酯酶5抑制剂，已于乌兹别克斯坦获批用于治疗勃起功能障碍，并预计就相同适应症获得中国国家药品监督管理局的新药申请批准。","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1322345.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HSTECH","HSCEI","BK4614","02630"],"gpt_icon":0},{"id":"2546722782","title":"旺山旺水港股IPO及境內未上市股份「全流通」獲中國證監會備案","url":"https://stock-news.laohu8.com/highlight/detail?id=2546722782","media":"格隆汇APP","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546722782?lang=zh_tw&edition=fundamental","pubTime":"2025-06-26 19:10","pubTimestamp":1750936200,"startTime":"0","endTime":"0","summary":"格隆汇6月26日｜中国证监会国际合作司发布关于苏州旺山旺水生物医药股份有限公司境外发行上市及境内未上市股份“全流通”备案通知书，公司拟发行不超过30,441,500股境外上市普通股并在香港联合交易所上市。公司25名股东拟将所持合计49,079,333股境内未上市股份转为境外上市股份，并在香港联合交易所上市流通。               \n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2025-06-26/doc-infcmcyh1410462.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["YANG","07226","BK4614","02630"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}]}}